• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

2020 年及以后的前列腺癌早期检测:欧盟和欧盟委员会的事实和建议。

Early Detection of Prostate Cancer in 2020 and Beyond: Facts and Recommendations for the European Union and the European Commission.

机构信息

Department of Development and Regeneration, University Hospital KU Leuven, Leuven, Belgium.

Department of Urology, Erasmus University Medical Center, Rotterdam, The Netherlands.

出版信息

Eur Urol. 2021 Mar;79(3):327-329. doi: 10.1016/j.eururo.2020.12.010. Epub 2020 Dec 29.

DOI:10.1016/j.eururo.2020.12.010
PMID:33384200
Abstract

The burden of prostate cancer is increasing. Therefore, we need to implement a contemporary, organized, risk-stratified program for early detection to reduce both the harm from the disease and potential overdiagnosis and overtreatment, while avoiding underdiagnosis to considerably improve the harm-to-benefit ratio.

摘要

前列腺癌的负担正在增加。因此,我们需要实施一个现代的、有组织的、风险分层的早期检测计划,以减少疾病的危害和潜在的过度诊断和过度治疗,同时避免漏诊,从而显著提高危害-效益比。

相似文献

1
Early Detection of Prostate Cancer in 2020 and Beyond: Facts and Recommendations for the European Union and the European Commission.2020 年及以后的前列腺癌早期检测:欧盟和欧盟委员会的事实和建议。
Eur Urol. 2021 Mar;79(3):327-329. doi: 10.1016/j.eururo.2020.12.010. Epub 2020 Dec 29.
2
Structured Population-based Prostate-specific Antigen Screening for Prostate Cancer: The European Association of Urology Position in 2019.基于人群的前列腺特异性抗原筛查前列腺癌:欧洲泌尿外科学会 2019 年立场声明。
Eur Urol. 2019 Aug;76(2):142-150. doi: 10.1016/j.eururo.2019.04.033. Epub 2019 May 12.
3
Overdiagnosis and overtreatment of prostate cancer.前列腺癌的过度诊断与过度治疗。
Eur Urol. 2014 Jun;65(6):1046-55. doi: 10.1016/j.eururo.2013.12.062. Epub 2014 Jan 9.
4
Re: Effects of Magnetic Resonance Imaging Targeting on Overdiagnosis and Overtreatment of Prostate Cancer.关于:磁共振成像靶向对前列腺癌过度诊断和过度治疗的影响。
Eur Urol. 2022 Oct;82(4):440. doi: 10.1016/j.eururo.2022.07.016. Epub 2022 Jul 27.
5
Breast, prostate, and thyroid cancer screening tests and overdiagnosis.乳腺癌、前列腺癌和甲状腺癌筛查测试与过度诊断。
Curr Probl Cancer. 2017 Jan-Feb;41(1):71-79. doi: 10.1016/j.currproblcancer.2016.11.006. Epub 2016 Dec 20.
6
What chance do we have to decrease prostate cancer overdiagnosis and overtreatment? A narrative review.我们有多大机会减少前列腺癌的过度诊断和过度治疗?一项叙述性综述。
Acta Biomed. 2019 Dec 23;90(4):423-426. doi: 10.23750/abm.v90i4.9070.
7
Multicriteria Decision Support Would Avoid Overdiagnosis and Overtreatment.多标准决策支持可避免过度诊断和过度治疗。
Stud Health Technol Inform. 2020 Nov 23;275:172-176. doi: 10.3233/SHTI200717.
8
Prostate cancer overdiagnosis and overtreatment.前列腺癌过度诊断与过度治疗。
Curr Opin Endocrinol Diabetes Obes. 2013 Jun;20(3):204-9. doi: 10.1097/MED.0b013e328360332a.
9
Prostate MRI can reduce overdiagnosis and overtreatment of prostate cancer.前列腺磁共振成像(MRI)可以减少前列腺癌的过度诊断和过度治疗。
Acad Radiol. 2015 Aug;22(8):1000-6. doi: 10.1016/j.acra.2015.02.006. Epub 2015 Mar 17.
10
The need for active surveillance for low risk prostate cancer.对低风险前列腺癌进行主动监测的必要性。
Expert Rev Anticancer Ther. 2017 Jun;17(6):487-489. doi: 10.1080/14737140.2017.1319767. Epub 2017 Apr 21.

引用本文的文献

1
Performance of GPT-4 for automated prostate biopsy decision-making based on mpMRI: a multi-center evidence study.基于多参数磁共振成像的GPT-4在前列腺自动活检决策中的性能:一项多中心证据研究。
Mil Med Res. 2025 Jul 7;12(1):33. doi: 10.1186/s40779-025-00621-3.
2
Screening for Prostate Cancer with Prostate-specific Antigen.使用前列腺特异性抗原筛查前列腺癌。
Eur Urol Open Sci. 2024 Aug 31;74:71-72. doi: 10.1016/j.euros.2024.01.010. eCollection 2025 Apr.
3
Perceptions, Knowledge, and Attitudes of General Population About Prostate Cancer-Associated Risk Factors: A Systematic Review of Qualitative Studies Focusing on Lifestyle.
普通人群对前列腺癌相关危险因素的认知、知识和态度:一项聚焦生活方式的定性研究系统评价
Curr Oncol Rep. 2025 Apr;27(4):375-389. doi: 10.1007/s11912-025-01653-7. Epub 2025 Mar 18.
4
Utility of Combining Prostate Health Index and Magnetic Resonance Imaging for the Diagnosis of Prostate Cancer.联合前列腺健康指数与磁共振成像诊断前列腺癌的效用
Int J Urol. 2025 Jun;32(6):658-663. doi: 10.1111/iju.70024. Epub 2025 Mar 17.
5
Prevention of infectious complications after transrectal ultrasound-guided prostate biopsy: comparison of povidone-iodine, chlorhexidine, and formalin disinfection.经直肠超声引导下前列腺穿刺活检术后感染并发症的预防:聚维酮碘、氯己定和福尔马林消毒的比较
World J Urol. 2025 Feb 7;43(1):107. doi: 10.1007/s00345-025-05498-4.
6
Cancer detection in patients with prostate-specific antigen levels within the grey zone: can synthetic magnetic resonance imaging aid in the differentiation between prostate cancer and noncancerous lesions?前列腺特异性抗原水平处于灰色区域的患者的癌症检测:合成磁共振成像能否有助于区分前列腺癌和非癌性病变?
Quant Imaging Med Surg. 2024 Dec 5;14(12):9157-9168. doi: 10.21037/qims-24-1014. Epub 2024 Nov 29.
7
[Early detection of prostate cancer-individualized, risk-adapted and successful].[前列腺癌的早期检测——个体化、风险适应性且成功]
Urologie. 2025 Jan;64(1):14-23. doi: 10.1007/s00120-024-02478-1. Epub 2024 Nov 28.
8
Health Professionals' Perceptions about Prostate Cancer-A Focus Group Study.健康专业人员对前列腺癌的看法——一项焦点小组研究
Cancers (Basel). 2024 Aug 29;16(17):3005. doi: 10.3390/cancers16173005.
9
Prostate Cancer Screening in Young Men.年轻男性的前列腺癌筛查
J Pers Med. 2024 Jul 31;14(8):818. doi: 10.3390/jpm14080818.
10
[Risk-adapted early detection program for prostate cancer 2.0-position paper of the German Society of Urology 2024].[前列腺癌风险适应性早期检测计划2.0——德国泌尿外科学会2024年立场文件]
Urologie. 2024 Sep;63(9):893-898. doi: 10.1007/s00120-024-02437-w. Epub 2024 Aug 12.